Protracted withdrawal from SSRIs
Protracted withdrawal is antidepressant withdrawal that keeps going after the first six weeks off the medication. UK guidance and the Royal College of Psychiatrists accept that for some people withdrawal lasts months, but how often this happens is not known. Much of what is known comes from people describing their own experience, some of whom report symptoms lasting a year or more. It can be mistaken for depression coming back, so a careful review with a prescriber matters.
Also called: Protracted withdrawal, PAWS, Post-acute withdrawal syndrome, Persistent post-withdrawal disorder.
Written by Alena Kozlova, PhD, from published studies and prescribing information.
Definition medically reviewed by Dr. Jason Tan, Consultant Psychiatrist, on November 11, 2026, this definition only. Next review: November 11, 2027.
How long does protracted SSRI withdrawal last?
The honest answer is a wide range. The US label for Lexapro says adverse reactions have been reported on stopping, and that a gradual reduction in the dose rather than abrupt cessation is recommended whenever possible. It puts no length on them.
UK guidance from the NHS fills that in. Withdrawal symptoms usually begin within a few days of starting to come off and last a few weeks, the NHS says, but they can be severe for some people, start weeks or months later and last for months or longer, and that may be more likely the longer you have taken antidepressants or the higher your dose.
The long end has its first detailed count in a 2020 analysis of narratives from a withdrawal forum. Before it, protracted withdrawal had been described in a few case reports and nothing more. The analysis picked out 69 people who had taken an antidepressant continuously for six months or more and then had new or more intense symptoms lasting beyond the first six weeks off it: by their last post, symptoms had run for a median of 26 months, with a mean of 37 and a range of 5 to 166 months. Those people were selected because their withdrawal had already dragged on, and the forum founder was one of the authors, so the figure shows how long it can run, not how long it usually does.
The same 69 reports say what it consists of. Affective symptoms came up for 81%, mostly anxiety, depression, emerging suicidality and agitation. Physical ones came up for 75%, mostly headache, fatigue, dizziness, brain zaps, visual changes, muscle aches, tremor, diarrhea and nausea. Sleep problems were mentioned by 44% and trouble with thinking and memory by 32%. The groups were largely unrelated to each other, so people had some of this and not the rest.
What are windows and waves?
Windows are the stretches when symptoms ease, waves the stretches when they come back. The words come from online peer support, and a 2021 account by the founder of one of those communities, published in Therapeutic Advances in Psychopharmacology, uses them in print: withdrawal symptoms tend to surge irregularly as waves and windows, while a return of depression builds more steadily. The same account says tolerance for dose reductions is individual, so a taper has to be watched and tailored as it goes.
It is one person reporting on thousands of others, not a study that counted anything, so read it as experience rather than evidence. Writing down when each window starts and ends still gives you and your prescriber something firmer than memory. If you are still coming down in dose, the pace of that is the next question, and the tapering page covers it.
Is it protracted withdrawal or depression coming back?
The two can feel alike, and telling them apart changes what you do next. A 2020 review by Cosci and Chouinard separates three things after a psychotropic medication is stopped: new withdrawal symptoms, rebound of the original symptoms, and persistent post-withdrawal disorder, which is the formal name for the protracted kind.
The part that holds up months later is the kind of symptom rather than the timing. The 2021 account describes withdrawal as announcing itself with a recognizable set of unusual neurophysiological symptoms, such as the electrical sensations people call brain zaps, or a sudden onset of dizziness, pain, nausea or insomnia, and says people describe them as new or exceptionally severe, nothing they had felt before. A return of the original condition is more consistent in pattern and takes longer to develop. Low mood can belong to either, so it is the odd physical symptoms with no other explanation that point to withdrawal. The 2019 Lancet Psychiatry analysis notes that withdrawal is also mistaken for recurrence often enough to keep people on medication they no longer need, and the side by side comparison is on the antidepressant discontinuation syndrome page.
What to do
Keep a dated log of symptoms and dose changes and bring it to your prescriber, who can help tell withdrawal from relapse and set the pace from here. The US labels for Lexapro and Zoloft say to reduce gradually rather than stop abruptly, and the Lexapro label says that if intolerable symptoms occur after a decrease in the dose, resuming the previously prescribed dose may be considered, so there is room to slow down. If your mood drops or stays low, tell your prescriber rather than waiting for the next appointment. If you have thoughts of harming yourself, call or text 988 in the US, or your local emergency number.
See smaller taper steps in the withClaro taper calculator
How withClaro helps
- A daily log that shows windows and waves over weeks
- Symptoms next to each dose change
- A PDF report to share with your prescriber
Get the withClaro app on the App Store
Related terms
Sources
- National Health Service (NHS). Antidepressants: Overview. NHS, 2026.
- Hengartner MP, Schulthess L, Sorensen A, Framer A. Protracted withdrawal syndrome after stopping antidepressants: a descriptive quantitative analysis of consumer narratives. Therapeutic Advances in Psychopharmacology, 2020.
- Framer A. What I have learnt from helping thousands of people taper off antidepressants and other psychotropic medications. Therapeutic Advances in Psychopharmacology, 2021.
- Cosci F, Chouinard G. Acute and persistent withdrawal syndromes following discontinuation of psychotropic medications. Psychotherapy and Psychosomatics, 2020.
- Horowitz MA, Taylor D. Tapering of SSRI treatment to mitigate withdrawal symptoms. The Lancet Psychiatry, 2019.
- U.S. Food and Drug Administration. Lexapro (escitalopram) tablets and oral solution: prescribing information. FDA / DailyMed, 2026.
- U.S. Food and Drug Administration. Zoloft (sertraline) tablets and oral solution: prescribing information. FDA / DailyMed, 2025.
All glossary terms